
Finnish researchers have identified genes which may predispose to anxiety disorders. Their research focussing on genes that influence human behavior found genes which show a statistical association with specific anxiety disorders. The research was conducted as part of the Academy of Finland Research Programme on Neuroscience (NEURO) and will be published in the October issue of the journal Biological Psychiatry.
Previously the team lead by Academy of Finland Research Fellow Iiris Hovatta have explored the genetic background of anxiety in experimental models. The current study follows up on these findings in humans using data collected as part of national Health 2000 Survey of 321 individuals diagnosed with anxiety disorder and 653 matched controls.
Hovatta says it was interesting that different genes showed evidence for association to specific types of anxiety disorders, such as panic disorder, social phobias or generalized anxiety disorder.
Specific alleles and haplotypes of six of the examined genes revealed some evidence for an association. The most significant evidence for an association with different anxiety disorder subtypes were with ALAD (d-aminolevulinate dehydratase) in social phobia, DYNLL2 (dynein light chain 2) in generalized anxiety disorder, and with PSAP (prosaposin) in panic disorder.
"Environmental factors, such as stressful life events, may trigger an anxiety disorder more easily in people who have a genetic predisposition to the illness," Hovatta says. The focus in the team's further studies will be to understand the molecular and cellular processes that link these genes to the regulation of anxiety behavior.
Currently, the team's international collaborators in Spain and the United States are trying to replicate these findings in their anxiety disorder datasets to see whether the identified genes also predispose to anxiety disorders in other populations.
A closer understanding of the genetics and neurobiology of anxiety disorders is expected to help improve treatment of the illness using both drugs and therapy-based approaches. For the time being, no targeted drugs are available for the treatment of anxiety disorders. Current medications benefit only about 50 percent of anxiety patients.
Donner J, Pirkola S, Silander K, et al. An Association Analysis of Murine Anxiety Genes in Humans Implicates Novel Candidate Genes for Anxiety Disorders Biol Psychiatry 2008; doi:10.1016/j.biopsych.2008.06.002 [Abstract]